Form 4: Director Sells Schwab Shares Under 10b5-1 Plan
Insider Transaction Report
A director of Charles Schwab Corporation sold over 10,000 shares of common stock at a weighted average price of $96.5682 per share under a pre-arranged trading plan.
Summary
- Stephen A. Ellis, a Director of The Charles Schwab Corporation (SCHW), reported a sale of common stock.
- The transaction involved the disposition of 10,725 shares.
- The shares were sold at a weighted average price of $96.5682 per share.
- The sale was executed on February 26, 2026.
- Following the transaction, Ellis beneficially owns 87,562.5296 shares, held indirectly by a Trust.
- The transaction was made pursuant to a Rule 10b5-1(c) trading plan, indicating a pre-scheduled sale.
- The reported beneficial ownership includes 327.7634 shares acquired through dividend reinvestment.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event. The sale is a routine insider transaction executed under a Rule 10b5-1 plan, which typically indicates a pre-scheduled disposition rather than a reaction to new information.
Positives
- The transaction was executed under a Rule 10b5-1(c) plan, indicating a pre-scheduled sale rather than a reaction to immediate market conditions or new material non-public information.
Negatives
- A director selling a significant number of shares could be perceived negatively by some investors, although the 10b5-1 plan mitigates concerns about opportunistic timing.
Future Outlook
No forward-looking statements or guidance are provided in this Form 4 filing, as it is a report of an individual insider transaction.
Industry Context
StockSavvy.ai notes that insider sales, even those under 10b5-1 plans, are routinely monitored by investors for insights into management's perception of future stock performance. While a 10b5-1 plan suggests a pre-determined sale, the volume and price point are still relevant data points for market participants tracking insider activity within the financial services sector. This transaction is a standard disclosure for a director of a major financial institution.
Comparison to Industry Standards
- This is a standard insider transaction report for a director of a publicly traded company. There are no specific industry benchmarks for individual insider sales, but the transaction volume represents a small fraction of Charles Schwab's overall market capitalization and daily trading volume.
- A similar sale by a director at a peer financial services firm like Fidelity, Morgan Stanley, or Bank of America would be viewed similarly as a routine disclosure, especially when executed under a 10b5-1 plan.
Related Party Transactions
- The reported sale of common stock by Stephen A. Ellis, a Director of The Charles Schwab Corporation, constitutes a related party transaction.
Stakeholder Impact
- Shareholders: May note the director's sale, but the execution under a 10b5-1 plan generally mitigates concerns about the timing or motivation of the sale.
Key Dates
| Date | Description |
|---|---|
| 02/26/2026 | Date of earliest transaction (sale of common stock) |
| 03/03/2026 | Signature date of the reporting person's attorney-in-fact |
Recommendation
holdThe reported insider sale by a director, executed under a pre-arranged 10b5-1 plan, is a routine disclosure and does not provide new fundamental information to alter the investment thesis for Charles Schwab Corporation. Investors should continue to hold based on broader company fundamentals and market conditions.
Keywords
Charles Schwab, SCHW, Form 4, Insider Trading, Stock Sale, Director, 10b5-1 Plan, Equity Transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.